ViewRay Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
268
- Stock Symbol
-
VRAYQ
ViewRay General Information
Description
ViewRay Inc designs, manufactures and markets MRIdian, an MR Image-Guided radiation therapy system to simultaneously image and treat cancer patients. MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that may arise when high magnetic fields interact with radiation beams.
Contact Information
Website
viewraysystems.comCorporate Office
- 2 Thermo Fisher Way
- Oakwood Village
- Bedford, OH 44146
- United States
Corporate Office
- 2 Thermo Fisher Way
- Oakwood Village
- Bedford, OH 44146
- United States
ViewRay Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 10.5K |
ViewRay Financials Summary
As of 31-Mar-2023, ViewRay has a trailing 12-month revenue of $106M.
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 579,490 | 737,825 | 905,379 | 470,144 |
| Revenue | 105,864 | 102,206 | 70,119 | 57,017 |
| EBITDA | (102,179) | (99,037) | (99,836) | (98,973) |
| Net Income | (110,415) | (107,330) | (110,048) | (107,908) |
| Total Assets | 233,159 | 271,397 | 321,807 | 261,552 |
| Total Debt | 85,133 | 86,404 | 67,880 | 68,072 |
ViewRay Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ViewRay Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
ViewRay Comparisons
Industry
Financing
Details
ViewRay Competitors (10)
One of ViewRay’s 10 competitors is Accuray, a Formerly VC-backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accuray | Formerly VC-backed | Madison, WI | ||||
| CivaTech Oncology | Venture Capital-Backed | Durham, NC | ||||
| Bomimed | Corporation | Winnipeg, Canada | ||||
| Neuroelectrics | Venture Capital-Backed | Barcelona, Spain | ||||
| TISSIUM | Venture Capital-Backed | Paris, France |
ViewRay Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ViewRay Patents
ViewRay Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160228728-A1 | Planning and control for magnetic resonance guided radiation therapy | Inactive | 11-Feb-2015 | ||
| WO-2015085008-A1 | Single-and multi-modality alignment of medical images in the presence of non-rigid deformations using phase correlation | Inactive | 03-Dec-2013 | ||
| JP-2016513560-A | System and method for linear accelerator radiation therapy using magnetic resonance imaging | Active | 15-Mar-2013 | ||
| WO-2014144399-A1 | Systems and methods for linear accelerator radiotherapy with magnetic resonance imaging | Inactive | 15-Mar-2013 | ||
| WO-2014144399-A9 | Systems and methods for linear accelerator radiotherapy with magnetic resonance imaging | Inactive | 15-Mar-2013 | A61N5/1049 |
ViewRay Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ViewRay Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ViewRay ESG
Risk Overview
Risk Rating
Updated December, 31, 2023
32.24 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Devices
Subindustry
of 199
Rank
Percentile
ViewRay FAQs
-
When was ViewRay founded?
ViewRay was founded in 2004.
-
Where is ViewRay headquartered?
ViewRay is headquartered in Bedford, OH.
-
What is the size of ViewRay?
ViewRay has 268 total employees.
-
What industry is ViewRay in?
ViewRay’s primary industry is Other Devices and Supplies.
-
Is ViewRay a private or public company?
ViewRay is a Public company.
-
What is ViewRay’s stock symbol?
The ticker symbol for ViewRay is VRAYQ.
-
What is ViewRay’s current revenue?
The trailing twelve month revenue for ViewRay is $106M.
-
Who are ViewRay’s competitors?
Accuray, CivaTech Oncology, Bomimed, Neuroelectrics, and TISSIUM are some of the 10 competitors of ViewRay.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
